24/7 Wall Street
25 Jun 2026, 18:35 UTC · 2h ago
Is Arm Holdings a Buy Near $347? The Case for Double-Digit Upside
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
24/7 Wall Street
25 Jun 2026, 18:35 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
Arm's data center royalty revenue more than doubled year-over-year in Q4. — Direct evidence of the transition to high-margin data center AI revenue justifies the stock's premium valuation.
+0.60Customer demand for Arm's AGI CPU exceeds $2 billion across FY2027 to FY2028. — Provides clear forward-looking revenue visibility for the company's first data center chip.
+0.50An upcoming Qualcomm/Nuvia verdict in Q4 calendar 2026 represents a significant downside risk to the stock price. — Legal outcomes regarding intellectual property can lead to sudden price corrections or royalty losses.
-0.40Arm is currently trading at a very high trailing P/E ratio of 474. — Extremely high multiples increase the stock's sensitivity to any earnings miss or growth slowdown.
Continue reading
6 related stories
Top 3 movers · tap to explore
Arm's operating margin compressed from 52.8% to 49.1% due to a 43% increase in R&D spending. — While driven by growth investment, margin contraction is generally viewed negatively by short-term investors.
-0.10Which stocks this story touches
Reported to have tripled its revenue in a year with a corresponding stock increase.
Described as one of the strongest performers in the AI infrastructure trade with a remarkable rally.
Strong growth in data center royalty revenue and a 'buy' rating with a target price above current levels, despite valuation concerns.
Mentioned as a key hyperscaler win for Arm and as part of a reaccelerating AI infrastructure trade.
Mentioned as having a $20 billion Graviton business growing in triple digits.
Listed as a multi-generation AGI CPU lead partner for Arm.
Identified as a key hyperscaler partner utilizing Arm's technology for AI compute.
Identified as a key hyperscaler partner utilizing Arm's technology for AI compute.
The upcoming Qualcomm/Nuvia trial is cited as a specific risk factor that could cause a price drop for Arm.
Described as one of the most 'whiplash-inducing' names, implying high volatility and instability.
Mentioned as a 'SoftBank overhang' acting as a risk factor for Arm.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
Seeking Alpha
2h ago
